日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A natural head start to MRD negativity in multiple myeloma

多发性骨髓瘤中微小残留病灶阴性的自然先发优势

Meermeier, Erin W

An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden

免疫刺激性 CELMoD 联合疗法可克服由高多发性骨髓瘤负荷引起的对 T 细胞衔接器的耐药性。

Meermeier, Erin W; Pfeffer, Kirsten; Stein, Caleb K; Sharik, Meaghen E; Du, Megan T; Tafoya Alvarado, Yuliza; Shi, Chang-Xin; Zhu, Yuan Xiao; Bergsagel, P Leif; Chesi, Marta

Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma

重编程谷氨酰胺代谢可增强BCMA-CAR T细胞的活性和多发性骨髓瘤的治疗效果

Navarro, Flor; Lozano, Teresa; Fuentes-García, Andrea; Sánchez-Moreno, Inés; Larrayoz, Marta; Justicia, Pedro; Perucha, Beatriz; Martinez-Tabar, Maialen; Martinez-Turrillas, Rebeca; Casares, Noelia; Martín-Otal, Celia; Gorraiz, Marta; Meermeier, Erin W; Chesi, Marta; Lake, Douglas; Bergsagel, P Leif; Santamaría, Eva; Calleja-Cervantes, María Eréndira; San Martín-Uriz, Patxi; Jordana-Urriza, Lorea; Agirre, Xabier; Hervás-Stubbs, Sandra; Rodriguez-Madoz, Juan Roberto; Martinez-Climent, José Ángel; Prosper, Felipe; Lasarte, Juan José

Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention

探索BCL2调控及其上游信号转导在多发性骨髓瘤维奈托克耐药中的作用:潜在的治疗干预途径

Fonseca, Rodrigo; Zhu, Yuan Xiao; Bruins, Laura A; Ahmann, Joseph; de Bonolo Campos, Cecilia; Braggio, Esteban; Chen, Xianfeng; Arribas, Mariano; Darvish, Susie; Welsh, Seth; Meermeier, Erin; Mangalaparthi, Kiran K; Kandasamy, Richard K; Ahmann, Greg; Wiedmeier-Nutor, J Erin; Pandey, Akhilesh; Chesi, Marta; Bergsagel, P Leif; Fonseca, Rafael

Two-pore channels in MR1-dependent presentation of Mycobacterium tuberculosis infection.

结核分枝杆菌感染的 MR1 依赖性呈递中的双孔通道

Karamooz Elham, Kim Se-Jin, Peterson Jessie C, Tammen Allison E, Soma Shogo, Soll Aviva C R, Meermeier Erin W, Khuzwayo Sharon, Lewinsohn David M

Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma

浆细胞身份逃逸驱动多发性骨髓瘤对BCMA靶向T细胞重定向疗法产生耐药性

Maura, Francesco; Freeman, Ciara L; Maclachlan, Kylee H; Ilundain, Marta Larrayoz; Ziccheddu, Bachisio; Meermeier, Erin W; Garces, Juan-Jose; Durante, Michael; Lee, Holly; Firestone, Ross; Menges, Meghan; Reid, Kayla; Diamond, Benjamin; Papadimitriou, Marios; Silva, Ariosto Siqueira; Sudalagunta, Praneeth Reddy; Leblay, Noemie; Ahn, Sungwoo; Fuller, Ethan; Briercheck, Edward; Sharik, Meaghen E; Du, Megan T; Agius, Phaedra; Hansen, Doris K; Song, Xiaofei; Zhao, Xiaohong; Meads, Mark B; Teer, Jamie; Jelinek, Tomas; Hagner, Patrick; Baz, Rachid; Alsina, Melissa; Ramasubramanian, Anusuya M; Smith, Eric; Giralt, Sergio A; Mailankody, Sham; Bergsagel, Leif P; Neri, Paola; Chesi, Marta; Martinez-Climent, Jose A; Locke, Frederick L; Bahlis, Nizar J; Landgren, Ola; Hamadeh, Issam; Usmani, Saad Z; Shain, Kenneth H

Next-Generation Therapies for Multiple Myeloma

多发性骨髓瘤的下一代疗法

Meermeier, Erin W; Bergsagel, P Leif; Chesi, Marta

Revisiting checkpoint inhibitors for myeloma: maintenance after stem cell transplant

重新审视骨髓瘤的免疫检查点抑制剂:干细胞移植后的维持治疗

Meermeier, Erin W; Bergsagel, P Leif

Human lung-resident mucosal-associated invariant T cells are abundant, express antimicrobial proteins, and are cytokine responsive

人肺黏膜相关不变T细胞数量丰富,表达抗菌蛋白,并对细胞因子有反应。

Meermeier, Erin W; Zheng, Christina L; Tran, Jessica G; Soma, Shogo; Worley, Aneta H; Weiss, David I; Modlin, Robert L; Swarbrick, Gwendolyn; Karamooz, Elham; Khuzwayo, Sharon; Wong, Emily B; Gold, Marielle C; Lewinsohn, David M

Monosomic loss of MIR15A/MIR16-1 is a driver of multiple myeloma proliferation and disease progression

MIR15A/MIR16-1单体缺失是多发性骨髓瘤增殖和疾病进展的驱动因素。

Chesi, Marta; Stein, Caleb K; Garbitt, Victoria M; Sharik, Meaghen E; Asmann, Yan W; Bergsagel, Matteo; Riggs, Daniel L; Welsh, Seth J; Meermeier, Erin W; Kumar, Shaji K; Braggio, Esteban; Bergsagel, P Leif